H2020Индивидуална стипендия2021–2023

SENSOR · Deciphering SENsing Of membrane satuRation with functional genetics (SENSOR)

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2021-09-01 → 2023-08-31
Финансиране от ЕС
175 572 €
Участници
1
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Механизмите, чрез които човешките клетки разпознават и регулират насищането на мазнините в мембраните си, остават неизвестни. Разбирането на този процес помага да се обясни развитието на заболявания като рак, при който промените в мазнините могат да доведат до устойчивост към химиотерапия.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Deciphering SENsing Of membrane satuRation with functional genetics (SENSOR)

Fatty acids (aka fats) are essential building blocks of membranes in each cell in our body, and dysregulation of their metabolism is associated with a wide-range of human conditions, including cancer, cardiovascular, neurodegenerative, and liver disease. For example, dysregulated fat production in the liver results in fatty-liver disease and inflammation that may lead to development of liver cancer. Related to this, cancer cells increase their fat synthesis to promote their uncontrolled growth, making this process an attractive anti-cancer target. Fats come in different sizes and shapes. A major way to distinguish fats is their saturation (i.e. saturated vs unsaturated fats), which is an intrinsic chemical feature that determines many properties of the cell membranes in which fats are incorporated into. Like fat synthesis, fat saturation is altered in many diseases, and for example elevated membrane saturation of cancer cells is associated with resistance to chemotherapy and increased metastatic spreading. In fact, there is even an enigmatic link between fat synthesis and saturation, with each one reciprocally influencing the other. Remarkably, despite the importance of controlling fat saturation in membranes, the fundamental mechanism(s) that sense and respond to changes in membrane saturation are unknown. In SENSOR we propose for the first time to directly address this issue using innovative genetic and cellular systems. To uncover the mechanisms and genes that sense and regulate fat saturation in human cells one must devise an approach that can report on fat saturation in living cells. Yet as analytical assays to measure fat saturation require dissolving the cells and extracting their fats, measuring saturation in living cells is an unsurmountable challenge that has largely prevented addressing this fundamental question. In SENSOR we have a solution to this problem. This solution is based on the use of engineered human cells together with a genetic approach that will allow us to test and identify which genes in the human genome are involved in regulating fat saturation. Project SENSOR has achieved a major goal - we developed a green fluorescent reporter, which can sense saturation of fats in the living cells. This reporter has been further used to identify which genes in human cells are regulating and sensing fat saturation. Additionally, such fluorescent reporter can and will be applied to find alternative treatments for fat metabolism related diseases, such as Adrenoleukodystrophy and Zellweger syndrome.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

All living cells must control the biophysical properties of their lipid membranes. Accordingly, dysregulation of the mechanisms underlying this process is associated with a wide range of human diseases, including amongst others metabolic disorders and cancer. In recent years, the role of fatty acid (FA) saturation in controlling membrane fluidity has gained great attention given the realization that the balance between unsaturated fatty acids (UFAs) and saturated fatty acids (SFAs) in the membrane is dynamic, and can be regulated to meet cellular needs. Herein, the SREBP-1 and -2 transcription factors play a pivotal role owing to their ability to control the level of cholesterol and fatty acid saturation. Our ability to understand the regulation of membrane fluidity and the intimate interaction between this property and SREBP regulation is hampered by the lack of experimental methods to faithfully follow FA saturation in a tempo-spatial resolution in live cells. To address this gap and to advance the field beyond the current state-of-the-art I therefore propose to combine my expertise in advanced functional genetic approaches with that of Prof. Zelcer in the molecular regulation of lipid metabolism, and specifically aim to: 1)Establish a universal and widely-applicable cellular system that reports on ER membrane saturation in mammalian cells through the use of an innovative fluorescent-based reporter.2)Determine the genetic traits that govern ER membrane saturation in an unbiased manner with state-of-the-art genome-wide CRISPR/Cas9-based assays.The proposed experiments will greatly enhance our understanding of the regulation of FA metabolism and will result in the generation of innovative and widely applicable experimental tools for in vitro and in vivo monitoring of membrane saturation. These studies may also inform on novel therapeutic strategies to treat lipid-associated disorders.

Оригинален текст от CORDIS (на английски).

Участници

  • ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · AmsterdamКоординаторНидерландия

Връзки

Данни: CORDIS, © Европейски съюз